Zacks Bull and Bear of the Day Highlights: CF Industries, Charlotte Russe, Genta,...

Zacks Bull and Bear of the Day Highlights: CF Industries, Charlotte Russe, Genta, DPL, Inc. and AXA Group

CHICAGO--(Business Wire)--
Zacks Equity Research highlights CF Industries (NYSE: CF) as the
Bull of the Day and Charlotte Russe (Nasdaq: CHIC) as the Bear of the
Day. In addition, Zacks Equity Research provides analysis on Genta,
Inc. (Nasdaq: GNTA), DPL, Inc. (NYSE: DPL) and AXA Group S.A. (NYSE:
AXA).

Full analysis of all these stocks is available at
http://at.zacks.com/?id=2676.

Here is a synopsis of all five stocks:

Bull of the Day: CF Industries (NYSE: CF)

CF Industries has leading market shares in many key fertilizers.
Strong domestic and international grain markets have produced an
exceptionally high global demand for fertilizer, translating into
substantially higher selling prices for all the products. The company
is optimistic about its phosphate business where the market is
expected to remain tight near term due to healthy offshore demand
growth in India and Brazil as well as higher application rates in the
US. This is likely to lead to higher prices and cash margins for
various fertilizers.

In addition, the company is likely to benefit from the proposed
nitrogen facility in Peru, which will address the nitrogen demand on
the west coast of Central and South America as well as Mexico where
there is no existing nitrogen facility. As a result, we rate the
shares a Buy with a target of $175.00.

Bear of the Day: Charlotte Russe (Nasdaq: CHIC)

Charlotte Russe reported disappointing fiscal third quarter
results, and management indicated that the problems will continue into
the fourth quarter. The company expects to earn $0.15-$0.23 per share,
which was well below the previous consensus of $0.30 and our previous
estimate of $0.28.

CHIC shares may look cheap at these levels, but we expect further
deterioration in its business. That, combined with its CEO retiring,
the company's new store openings, and macro headwinds will continue to
pressure Charlotte Russe's profit margin. We are reducing our fiscal
2008 EPS estimate from $1.30 to $1.18 and our fiscal 2009 EPS from
$1.40 to $1.00. Our estimates are well below the consensus view, and
we expect the consensus estimates to continue falling over the next
few months.

Latest Posts on the Zacks Analyst Blog:

Genta, Inc. (Nasdaq: GNTA)

After getting a "non-approvable" notice for its leading candidate,
Genasense, in 2006, Genta filed an appeal with the Food and Drug
Administration in April last year and got a positive response this
March. Positive results from the AGENDA trial will support the
worldwide filing of Genasense as a treatment for melanoma. However,
results from the phase III trial are not expected before end of 2008.

The future of Genasense still remains uncertain. In July 2007, the
European Medicines Agency (EMEA) indicated that approval of Genasense
in melanoma will require the conduct of another clinical study. Genta
believes that the AGENDA trial will be able to address the EMEA's
requirement adequately.

DPL, Inc. (NYSE: DPL)

DPL continues to benefit from its stable regulated electric power
operations. The first half of 2008 saw gains on sale of emission
allowances, successful completion of the scrubber project, higher
rates, mainly in the retail and wholesale segments, focus on debt
reduction and higher generation output.

However, increased purchased power and fuel costs, renewable
energy thrust in the new Ohio electric energy bill and uncertainty
over the successful allocation of new capital towards greater earnings
power remain concerns. We maintain a Buy recommendation on DPL common
stock with a six-month target price of $28.25.

AXA Group S.A. (NYSE: AXA)

AXA Group, through its subsidiaries provides financial protection
and asset management, services primarily in Western Europe, North
America, the Asia-Pacific region, the Middle East and Africa.

The company has positive cash flow in all of its operations, and
an increase in interest rates will be positive for the reinvestment of
its cash flow. In addition, higher interest rates will lead to higher
profit margins in the company's guaranteed insurance products. We are
forecasting a 5% equity return for the market for the next six months.
If there is a slight improvement in equity markets, this would feed
into stronger earnings for AXA's asset management, life insurance, and
property and casualty (P&C) insurance segments, as the value of its
equity portfolios would rise.

Get the most recent insight from Zacks Equity Research with the
free Profit from the Pros newsletter: http://at.zacks.com/?id=2649.

About the Bull and Bear of the Day

Every day, the analysts at Zacks Equity Research select two stocks
that are likely to outperform (Bull) or underperform (Bear) the
markets over the next 3-6 months.

About the Analyst Blog

Updated throughout every trading day, the Analyst Blog provides
analysis from Zacks Equity Research about the latest news and events
impacting stocks and the financial markets.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and
qualitative analysis to help investors know what stocks to buy and
which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly
traded stocks. Our analysts are organized by industry which gives them
keen insights to developments that affect company profits and stock
performance. Recommendations and target prices are six-month time
horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights
of the latest analysis from Zacks Equity Research. Subscribe to this
free newsletter today by visiting http://at.zacks.com/?id=2677.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which
was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew
he could find patterns in stock market data that would lead to
superior investment results. Amongst his many accomplishments was the
formation of his proprietary stock picking system; the Zacks Rank,
which continues to outperform the market by nearly a 3 to 1 margin.
The best way to unlock the profitable stock recommendations and market
insights of Zacks Investment Research is through our free daily email
newsletter; Profit from the Pros. In short, it's your steady flow of
Profitable ideas GUARANTEED to be worth your time! Register for your
free subscription to Profit from the Pros at
http://at.zacks.com/?id=4582.

Visit http://www.zacks.com/performance for information about the
performance numbers displayed in this press release.

Disclaimer: Past performance does not guarantee future results.
Investors should always research companies and securities before
making any investments. Nothing herein should be construed as an offer
or solicitation to buy or sell any security.

Zacks.com
Mark Vickery
312-265-9380
Visit: www.zacks.com

Copyright Business Wire 2008